UroGen Pharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.

About URGN

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.

CEO

Elizabeth Barrett

CEOElizabeth Barrett

Employees

235

Employees235

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

2004

Founded2004

Employees

235

Employees235

URGN Key Statistics

Market cap

454.49M

Market cap454.49M

Price-Earnings ratio

-3.06

Price-Earnings ratio-3.06

Dividend yield

—

Dividend yield—

Average volume

482.46K

Average volume482.46K

High today

$10.05

High today$10.05

Low today

$9.72

Low today$9.72

Open price

$10.01

Open price$10.01

Volume

262.21K

Volume262.21K

52 Week high

$20.70

52 Week high$20.70

52 Week low

$8.94

52 Week low$8.94

URGN News

TipRanks 10h

UroGen Pharma announces long-term follow up data from OPTIMA II Phase 2b study

UroGen Pharma (URGN) announced new data from the OPTIMA II Phase 2b study of UGN-102 for intravesical solution demonstrate clinically meaningful two-year durati...

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell